Table 1.

Correlation analyses of AOPPs with the serum levels of the LDL subclasses, carried out separately for the HVs and patients with MS.

	AOPPs (μmol/L)
	HV (N = 65)		MS (N = 65)
Variable (mg/dL)	r	p	r	p
LDL-C	0.26	0.0395	0.04	0.7305
LDL1-C	−0.03	0.8415	0.00	0.9841
LDL2-C	−0.30	0.0152	−0.30	0.0156
LDL3-C	−0.08	0.5151	−0.29	0.0181
LDL4-C	0.39	0.0011	−0.15	0.2323
LDL5-C	0.55	<0.0001	0.23	0.0658
LDL6-C	0.46	0.0001	0.72	<0.0001
LDL-FC	0.14	0.2657	−0.06	0.6482
LDL1-FC	0.00	0.9920	0.07	0.5599
LDL2-FC	−0.33	0.0074	−0.23	0.0632
LDL3-FC	−0.22	0.0835	−0.27	0.0288
LDL4-FC	0.27	0.0311	−0.17	0.1678
LDL5-FC	0.48	0.0001	0.16	0.1947
LDL6-FC	0.36	0.0032	0.70	<0.0001
LDL-TG	0.53	<0.0001	0.65	<0.0001
LDL1-TG	0.41	0.0008	0.55	<0.0001
LDL2-TG	0.12	0.3380	0.22	0.0732
LDL3-TG	0.00	0.9866	−0.07	0.5641
LDL4-TG	0.49	<0.0001	0.26	0.0335
LDL5-TG	0.58	<0.0001	0.63	<0.0001
LDL6-TG	0.33	0.0077	0.71	<0.0001
LDL-PL	0.23	0.0604	−0.02	0.8738
LDL1-PL	−0.02	0.8717	−0.02	0.8937
LDL2-PL	−0.30	0.0136	−0.34	0.0053
LDL3-PL	−0.10	0.4451	−0.31	0.0117
LDL4-PL	0.40	0.0008	−0.14	0.2602
LDL5-PL	0.54	<0.0001	0.20	0.1044
LDL6-PL	0.39	0.0012	0.70	<0.0001
LDL-apoB	0.41	0.0007	0.33	0.0084
LDL1-apoB	0.00	0.9700	0.06	0.6062
LDL2-apoB	−0.23	0.0660	−0.21	0.0912
LDL3-apoB	−0.02	0.8483	−0.25	0.0480
LDL4-apoB	0.47	0.0001	−0.05	0.6826
LDL5-apoB	0.58	<0.0001	0.34	0.0056
LDL6-apoB	0.52	<0.0001	0.76	<0.0001

The associations of the serum levels of AOPPs with the serum levels of lipids and apoB in the total LDL and the LDL subclasses were evaluated with Spearman correlation analyses. p-values < 0.0003 are considered statistically significant after a Bonferroni correction for multiple testing and are depicted in bold. AOPPs; advanced oxidation protein products; ApoB, apolipoprotein B; C, cholesterol; FC, free cholesterol; HV, healthy volunteer; LDL, low-density lipoprotein; MS, patient with metabolic syndrome; PL, phospholipid; r, Spearman’s correlation coefficient; TG, triglyceride.